News
Palantir’s New Healthcare Deal Boosts AI and Data Reach
Palantir Technologies Inc. (NASDAQ: PLTR) and OneMedNet Corp. (NASDAQ: ONMD) have agreed to a partnership that will leverage Palantir’s Artificial Intelligence Platform (AIP) to enhance its
GM's Billion-Dollar Bruise: GM's Strategic Pivot Makes It a Buy
General Motors (NYSE: GM) announced on Oct. 14 that it will take a significant $1.6 billion charge in its third-quarter earnings report results, a move directly tied to a strategic realignment
Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Novo Nordisk A/S (NYSE: NVO) recently announced plans to acquire Akero Therapeutics. The deal, which is valued at around $4.7 billion, is scheduled to close early in 2026. After initially moving
ASML Can Hit New Highs, But It Won’t Be Easy: Here’s Why
ASML’s (NASDAQ: ASML) stock price could hit new highs because it is well-positioned for the AI boom, and the chart action is bullish. Up 40% since early September, the market for this
Vertiv Stock Surges on Strategic CFO Hire and AI Momentum
On Oct. 13, 2025, the stock of Vertiv Holdings Co. (NYSE: VRT) surged over 6%, closing at a new 52-week high of $179.43. The catalyst wasn't a new product or a significant contract win, but
How Many Cryptocurrencies Exist?
The Zacks Analyst Blog Highlights Gold Fields, Franco-Nevada and AngloGold Ashanti
For Immediate Release
Chicago, IL – October 16, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
The Zacks Analyst Blog Highlights Shopify, Amazon, Wix.com and Commerce.com
For Immediate Release
Chicago, IL – October 16, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
The Zacks Analyst Blog Highlights Amazon, Microsoft, IonQ, Google, IBM
For Immediate Release
Chicago, IL – October 16, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised)
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.
This gene therapy is being evaluated for profound genetic hearing loss
Compared to Estimates, Pinnacle Financial (PNFP) Q3 Earnings: A Look at Key Metrics
For the quarter ended September 2025, Pinnacle Financial (PNFP) reported revenue of $544.8 million, up 16.7% over the same period last year. EPS came in at $2.27, compared to $1.86 in the year-ago
Great Southern Bancorp (GSBC) Q3 Earnings Beat Estimates
Great Southern Bancorp (GSBC) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.41 per share a year ago
Compared to Estimates, Home BancShares (HOMB) Q3 Earnings: A Look at Key Metrics
For the quarter ended September 2025, Home BancShares (HOMB) reported revenue of $277.67 million, up 7.6% over the same period last year. EPS came in at $0.61, compared to $0.50 in the year-ago
Pinnacle Financial (PNFP) Tops Q3 Earnings and Revenue Estimates
Pinnacle Financial (PNFP) came out with quarterly earnings of $2.27 per share, beating the Zacks Consensus Estimate of $2.05 per share. This compares to earnings of $1.86 per share a year ago. These
SL Green (SLG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended September 2025, SL Green (SLG) reported revenue of $149.67 million, up 7.2% over the same period last year. EPS came in at $1.58, compared to -$0.21 in the year-ago quarter.
Synovus (SNV) Reports Q3 Earnings: What Key Metrics Have to Say
For the quarter ended September 2025, Synovus Financial (SNV) reported revenue of $611.06 million, up 8.2% over the same period last year. EPS came in at $1.46, compared to $1.23 in the year-ago
Home BancShares (HOMB) Q3 Earnings and Revenues Beat Estimates
Home BancShares (HOMB) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.5 per share a year ago. These
Waste Management (WM) Stock Dips While Market Gains: Key Facts
Waste Management (WM) ended the recent trading session at $213.69, demonstrating a -2.03% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.4%. At the
MakeMyTrip (MMYT) Stock Sinks As Market Gains: What You Should Know
MakeMyTrip (MMYT) closed the most recent trading day at $90.40, moving -1.04% from the previous trading session. This change lagged the S&P 500's daily gain of 0.4%. Elsewhere, the Dow lost 0.04%